Results 11 to 20 of about 112,750 (251)

The use of angiotensin-converting enzyme inhibitors in general medicine

open access: yesSouth African Family Practice, 2012
Angiotensin-converting enzyme (ACE) inhibitors are a class of drugs commonly used in the management of hypertension, congestive heart failure, cerebrovascular disease, stable coronary heart disease and diabetes-associated nephropathy.
M.L.I. Mashitisho
doaj   +1 more source

SGLT2 Inhibitors for Nephrologists

open access: yesEuropean Medical Journal Nephrology, 2022
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are the mainstay of therapy for the prevention of progressive renal damage in diabetic and non-diabetic kidney diseases, especially glomerulonephritides.
Mufti Baleegh-ur-Raheem Mahmood   +1 more
doaj   +1 more source

Angiotensin-converting Enzyme Inhibitors-induced Angioedema

open access: yesJournal of Cardiovascular Emergencies, 2018
Angiotensin-converting enzyme inhibitors (ACEI) are widely used drugs nowadays in treating patients diagnosed with cardiovascular disorders. We present two consecutive cases of acquired angioedema caused by the administration of enalapril and lisinopril ...
Chiriac Anca   +3 more
doaj   +1 more source

Pharmacotherapy and analysis of gaseous mediators in hypertensive patients

open access: yesRevista da Escola de Enfermagem da USP, 2015
OBJECTIVE To evaluate the effect of using antihypertensive classes of drugs of the calcium channel antagonists and inhibitors of angiotensin-converting enzyme in plasma concentrations of hydrogen sulfide and nitric oxide in patients with hypertension ...
Letícia Palota Eid   +4 more
doaj   +1 more source

Angiotensin-Converting Enzyme Inhibitors and Angioedema [PDF]

open access: yesAllergy, Asthma and Immunology Research, 2010
To investigate the incidence and clinical characteristics of angioedema associated with the use of angiotensin-converting enzyme inhibitors (ACEIs) in an outpatient allergy department.A retrospective review of medical records of new patients seen in an allergy clinic.
Sánchez-Borges, Mario   +1 more
openaire   +2 more sources

A new angiotensin-converting enzyme inhibitor from Peperomia pellucida (L.) Kunth

open access: yesAsian Pacific Journal of Tropical Biomedicine, 2019
Objective: To isolate, identify, and evaluate a new angiotensin-converting enzyme inhibitor from Peperomia pellucida (L.) Kunth herbs. Methods: A dried sample of Peperomia pellucida herb was successively macerated with n-hexane and ethyl acetate.
Islamudin Ahmad   +7 more
doaj   +1 more source

EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE

open access: yesРациональная фармакотерапия в кардиологии, 2015
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease.
Jose Lopez-Sendon   +10 more
doaj   +3 more sources

The angiotensin converting enzyme inhibitors – alternative clinical applications

open access: yesJournal of Medical Science, 2014
Angiotensin converting enzyme inhibitors have emerged as a useful strategy in the management of hypertension and other cardiovascular system-related diseases.
Beata Stanisz   +2 more
doaj   +1 more source

Effect of ACE Inhibitors, ARBs, and Other Antihypertensive Drugs on Hypertensive Patients with COVID-19 Infection

open access: yesNovelty in Biomedicine
Background: To investigate differences in disease severity and outcomes among COVID-19 patients with a history of hypertension using angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and other antihypertensive drugs.
Seyedpouzhia Shojaei   +7 more
doaj   +1 more source

Angiotensin-Converting Enzyme Inhibitors [PDF]

open access: yesCirculation, 2005
Background— Angiotensin-converting enzyme (ACE) inhibitors are valuable agents for the treatment of hypertension, heart failure, and other cardiovascular and renal diseases. The cardioprotective effects of ACE inhibitors are mediated by blockade of both conversion of angiotensin (Ang) I to Ang II and
Hongmei, Peng   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy